We are live on ! Find out more
IP

Invenire Partners Portfolio holdings

AUM $65.4M Turnover 47.22%
1-Year Est. Return 18.1%
This Fund
S&P 500
This Quarter Est. Return
+3.15%
1 Year Est. Return
-18.1%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$65.4M
AUM Growth
-$9.9M
Cap. Flow
-$2.47M
Cap. Flow %
-3.78%
Top 10 Hldgs %
57.26%
Holding
36
New
7
Increased
10
Reduced
3
Closed
10
Avg Time Held Equity + Options
0.5 years
Top 10 Avg Time Held Equity + Options
0.3 years
Top 20 Avg Time Held Equity + Options
0.5 years
Avg Time Held Equity only
0.5 years
Top 10 Avg Time Held Equity only
0.3 years
Top 20 Avg Time Held Equity only
0.5 years

Top Buys

Rank Stock Value
1
EGIO icon
Edgio, Inc. Common Stock
EGIO
+$3.11M
2
APYX icon
Apyx Medical
APYX
+$2.63M
3
DCGO icon
DocGo
DCGO
+$2.48M
4
OPRX icon
OptimizeRx
OPRX
+$2.08M
5
NOTV icon
Inotiv
NOTV
+$1.74M

Top Sells

Rank Stock Value
1
NOA icon
North American Construction
NOA
+$3.38M
2
UIS icon
Unisys
UIS
+$3.22M
3
DLA icon
Delta Apparel Inc.
DLA
+$2.73M
4
CMCO icon
Columbus McKinnon
CMCO
+$1.95M
5
SHYF icon
The Shyft Group
SHYF
+$1.92M

Sector Composition

Rank Sector Weight
1 Healthcare 34.72%
2 Technology 26.01%
3 Industrials 15.3%
4 Communication Services 9.23%
5 Consumer Discretionary 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
HROW icon
1
Harrow
HROW
$1.04B
$5.48M 8.38%
453,794
-60,000
-12% -$487K
2021 Q4
3 quarters
DHX icon
2
DHI Group
DHX
$207M
$5.19M 7.93%
964,180
+280,078
+41% +$1.47M
2021 Q4
3 quarters
TTI icon
3
TETRA Technologies
TTI
$776M
$4.25M 6.5%
1,184,400
+71,900
+6% +$283K
2021 Q4
3 quarters
APYX icon
4
Apyx Medical
APYX
$102M
$4.25M 6.49%
945,711
+367,758
+64% +$2.63M
2021 Q4
3 quarters
INFU icon
5
InfuSystem Holdings
INFU
$274M
$3.26M 4.99%
466,736
+66,233
+17% +$555K
2021 Q4
3 quarters
PAAI icon
6
Paradium.AI, Inc.
PAAI
$38.9M
$3.16M 4.83%
241,355
-145,434
-38% -$1.61M
2022 Q1
2 quarters
CTLP icon
7
DELISTED
Cantaloupe
CTLP
$3.09M 4.73%
888,295
+186,599
+27% +$1.02M
2021 Q4
3 quarters
PAR icon
8
PAR Technology
PAR
$718M
$2.97M 4.54%
100,569
+3,000
+3% +$111K
2021 Q4
3 quarters
EGIO icon
9
DELISTED
Edgio, Inc. Common Stock
EGIO
$2.92M 4.46%
+26,250
New +$3.11M
2022 Q3
0 quarters
MCS icon
10
Marcus Corp
MCS
$879M
$2.88M 4.4%
207,128
– –
2021 Q4
3 quarters
DCGO icon
11
DocGo
DCGO
$25.2M
$2.73M 4.17%
+275,100
New +$2.48M
2022 Q3
0 quarters
DNOW icon
12
DNOW Inc
DNOW
$2.93B
$2.71M 4.14%
269,350
– –
2021 Q4
3 quarters
EVRI icon
13
DELISTED
Everi Holdings
EVRI
$2.51M 3.83%
154,500
+42,500
+38% +$783K
2022 Q1
2 quarters
PRIM icon
14
Primoris Services
PRIM
$4.01B
$2.36M 3.62%
145,500
– –
2021 Q4
3 quarters
AORT icon
15
Artivion
AORT
$1.09B
$2.34M 3.59%
169,414
+55,000
+48% +$1.11M
2022 Q1
2 quarters
TTEC icon
16
TTEC Holdings
TTEC
$79.9M
$2.25M 3.43%
50,682
– –
2021 Q4
3 quarters
SQNS icon
17
Sequans Communications SA
SQNS
$36.2M
$2.13M 3.25%
23,814
+772
+3% +$64.5K
2021 Q4
3 quarters
CLAR icon
18
Clarus
CLAR
$139M
$2.12M 3.24%
157,090
-20,000
-11% -$389K
2021 Q4
3 quarters
INVE icon
19
INVE Technologies, Inc. Common Stock
INVE
$54.8M
$2.02M 3.09%
160,927
+41,784
+35% +$572K
2022 Q2
1 quarter
NOTV icon
20
DELISTED
Inotiv
NOTV
$1.6M 2.45%
+95,000
New +$1.74M
2022 Q3
0 quarters
OPRX icon
21
OptimizeRx
OPRX
$165M
$1.56M 2.38%
+105,000
New +$2.08M
2022 Q3
0 quarters
SRTS icon
22
Sensus Healthcare
SRTS
$45.4M
$1.49M 2.28%
+118,867
New +$1.42M
2022 Q3
0 quarters
SNCR icon
23
DELISTED
Synchronoss Technologies
SNCR
$1.39M 2.13%
135,508
– –
2021 Q4
3 quarters
SRXH
24
SRX Global
SRXH
$23.3M
$700K 1.07%
450
– –
2021 Q4
3 quarters
CLAR icon
25
PUT
Clarus
CLAR
$139M
$58.5K 0.09%
+300
New +$5.84K
2022 Q3
0 quarters
1
2

Similar funds

ACK
Andrew C. Karlinski $66M AUM 13.05% 1-Year Est. Return
LDFO
Louis-Dreyfus Family Office Wilton, Connecticut $64.7M AUM 21.08% 1-Year Est. Return
SAM
Stringer Asset Management Memphis, Tennessee $64.2M AUM 16.57% 1-Year Est. Return
BVLP
Bailey Value Limited Partnership Danvers, Massachusetts $63.4M AUM 15.1% 1-Year Est. Return
HLOC
H.L. Ormond & Company Greenville, North Carolina $62.4M AUM 11.15% 1-Year Est. Return
FFM
Forager Funds Management Sydney, Australia $61.3M AUM 30.64% 1-Year Est. Return
BI
Beecher Investors Darien, Connecticut $60.9M AUM 0.18% 1-Year Est. Return
BI
Bregal Investments New York $60.8M AUM 77.71% 1-Year Est. Return

Invenire Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Invenire Partners held 36 positions worth $65.4M, down 13% from $75.3M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Invenire Partners withdrew a net $2.47M in Q3 2022, closing 10 positions and reducing 3 holdings. Its most notable exit was North American Construction, an estimated $3.38M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.

Against the trend, Invenire Partners opened a new position in Edgio, Inc. Common Stock worth $2.92M.

  • Invenire Partners's largest Q3 2022 buy was Edgio, Inc. Common Stock: 26,250 shares worth $2.92M.
  • Invenire Partners added most to Apyx Medical in Q3 2022, an estimated $2.63M increase.
  • Invenire Partners's biggest Q3 2022 reduction was Paradium.AI, Inc., cutting an estimated $1.61M.
  • Invenire Partners fully exited North American Construction in Q3 2022, selling an estimated $3.38M.
  • Invenire Partners's ten largest holdings make up 57% of its $65.4M portfolio in Q3 2022.
  • Invenire Partners opened 7 new positions and closed 10 in Q3 2022.
  • Invenire Partners's portfolio value fell 13% quarter-over-quarter to $65.4M.

Based on Invenire Partners's 13F filing for Q3 2022, filed 14 Nov 2022.